SQUIBB &lt;SQB> INTERESTED BUYING CETUS Robert Fildes, president chief executive Cetus Corp &lt;CTUS.O>, told Reuters Squibb Corp interested buying Cetus. Earlier companies Squibb buy Cetus pct equity postion Cetus 40 mln dlrs. "This attempt Squibb major majority holder Cetus," Fildes told Reuters interview. "Squibb approached indication acquire interested kind arrangement," Fildes. Squibb reached comment late comments Fildes. Squibb Cetus' pharmaceutical partner equity position Cetus. Eastman Kodak &lt;EK> W.R. Grace &lt;WR> joint ventures Cetus, owns equity position company, Fildes. Cetus venture Kodak develp diagnostic products Grace develop agricultural products. Earlier, Squibb Cetus announced joint statement agreement principle form joint venture develop biotechnology products fields. part deal Squibb license Cetus' anticancer agents, including interleukin-2, development. Squibb sell drugs Japan markets North American Western Europe. "We deal understood Cetus build fully integrated business North America Europe," Fildes. Squibb good partner Squibb major joint venture Japan sales capabilities market. Fildes Cetus shunned licensing arrangements pharmaceutical companies wanted build business. large corporations invested small biotech firms. Squibb's investment Cetus made biotechnology. Fildes attractive Cetus wanted partner relationship large number biotechnology companies." Fildes strategy partners drug areas diagnostics agriculture, "keep biggest developments anticancer drugs ourselves." Fildes partnership Squibb broaden company's reach big money making areas cardiovascular, anti-infective anti-inflammatory markets. Squibb investming 75 mln dlrs Cetus' research years. "Squibb putting 75 mln dlrs research development make happen, equity position part package simply demonstrate seriousness partnership," Fildes.